Cost‐Effectiveness of Pharmacogenetics‐Guided Warfarin Therapy vs. Alternative Anticoagulation in Atrial Fibrillation

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|95|2|199-207

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.95, Iss.2, 2014-02, pp. : 199-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heparin bridging in warfarin anticoagulation therapy initiation could increase bleeding in non‐valvular atrial fibrillation patients: a multicenter propensity‐matched analysis

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 2, 2015-02 ,pp. : 182-190

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anticoagulation after Catheter Ablation of Atrial Fibrillation Guided by Implantable Cardiac Monitors

By  

PACING AND CLINICAL ELECTROPHYSIOLOGY, Vol. 38, Iss. 6, 2015-06 ,pp. : 688-693

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chronic Atrial Fibrillation in the Elderly: Risks vs. Benefits of Long‐term Anticoagulation

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 33, Iss. 4, 1985-04 ,pp. : 298-302

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation

By  

JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (ELECTRONIC), Vol. 27, Iss. 4, 2015-04 ,pp. : 190-196

John Wiley & Sons Inc

Access to resources Recommend Favorite

New Alternative Anticoagulants in Atrial Fibrillation: The Move Beyond Warfarin.

By  

Reviews on Recent Clinical Trials, Vol. 8, Iss. 2, 2013-01 ,pp. : 78-85

Bentham Science Publishers

Access to resources Recommend Favorite